|
|
 |
|
Viewing report
|
|
|
|
The Asian Cardiovascular Market Outlook to 2014: Regional and Therapeutic Analysis, Pipeline Impact and Growth Opportunities
Business Insights, March 2009, Pages: 244
The Asian cardiovascular market demonstrated robust sales, unlike the global market which has begun to slow down due to patent expiries of class leading products and strong generic competition. The emerging ten Asian markets analyzed in this report is a mixture of developed nations like South Korea, Taiwan, Hong Kong, Singapore and Malaysia, and developing markets such as China, India, Thailand, Philippines and Indonesia. Although these markets have lower healthcare expenditure per head compared to the US and EU, the Asian markets are regarded as the potential growth markets of the health services industry and consequently the pharmaceutical sector. The market is also being driven by the shift of focus from primary care to specialty care. In comparison to the western markets drug patent expiries minimally affect proprietary brand growth dynamics in Asia. Regional customization of brand prices and aggressive marketing strategies have positioned branded drugs in direct competition with generic brands.
Customers who bought this item also bought
The Asia-Pacific Pharmaceuticals Sectors : A Company and Industry Analysis (October 2003)
The Asia Pacific Pharmaceuticals Sectors : A Company and Industry Analysis (March 2003)
Cardiovascular Drug Delivery - Technologies, Markets and Companies
Commercial Insight: Cardiovascular Market Overview - Raft of Patent Expires Threaten Blockbusters
Strategic Perspectives 2001: Cardiovascular Gene Therapy - Injecting New Life Into Mature Markets
Commercial Insight: Antithrombotics - Pipeline Products to Dampen the Impact of Patent Expiries and Cost Containment Initiatives
COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact
Future Growth Opportunities in Generics: The Impact of Consolidation on Market and Competitive Dynamics
China Diagnostic Reagent Market Report, 2007-2009
China Diagnostic Reagent Market Report, 2007-2009
Hungary Pharmaceuticals and Healthcare Report Q3 2009
Mitsubishi Tanabe Pharma: Pipeline - Products - Performance - Potential
|
|
|
|
